Prevalence of osteosarcopenia in patients with end-stage knee OA who underwent total knee arthroplasty.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 41171458.
- Also identified by DOI 10.1007/s00198-025-07731-7 and PMC identifier 12847086.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study investigated the prevalence of osteoporosis and sarcopenia in patients with end-stage knee osteoarthritis (OA) undergoing total knee arthroplasty (TKA). In this retrospective cohort study, all patients with end-stage knee OA who underwent TKA between April 2022 and May 2023 were included. Preoperative appendicular lean mass index and bone mineral density were measured using dual-energy X-ray absorptiometry. A total of 1755 patients (mean age, 73.5 ± 6.8 years) underwent TKA, with women comprising the majority (1554 patients, 88.5%). The prevalence of osteoporosis and sarcopenia was significantly higher in women than in men. Osteoporosis affected 51.9% of women versus 21.4% of men, and sarcopenia affected 42.2% of women versus 36.3% of men. The prevalence of osteosarcopenia was more than twice as high in women (25.9%) as in men (11.4%). Osteosarcopenia was present in 24.1% of patients with end-stage knee OA undergoing TKA, exceeding rates in the general population. The condition was particularly prevalent among elderly female patients.
Medical subject headings
- Arthroplasty, Replacement, Knee
- Osteoarthritis, Knee
- Sarcopenia